2010
DOI: 10.1182/blood-2008-03-143370
|View full text |Cite
|
Sign up to set email alerts
|

Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
52
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(65 citation statements)
references
References 36 publications
12
52
1
Order By: Relevance
“…Aneuploid donors and their wild-type littermates expressed the CD45.2 isoform, whereas the common wild-type competitor expressed the CD45.1 isoform. We chose to use a CD45.1 common donor because previous studies had shown that CD45.1 HSCs exhibit decreased fitness when compared with CD45.2 HSCs in competition assays (Waterstrat et al 2010), thus giving the CD45.2 aneuploid donors a slight advantage in these experiments. Additionally, we used CD45.1 recipients to unambiguously quantify the contribution from aneuploid and euploid wild-type littermate donors.…”
Section: Aneuploidy Decreases Hsc Competitive Fitness In Vivomentioning
confidence: 99%
“…Aneuploid donors and their wild-type littermates expressed the CD45.2 isoform, whereas the common wild-type competitor expressed the CD45.1 isoform. We chose to use a CD45.1 common donor because previous studies had shown that CD45.1 HSCs exhibit decreased fitness when compared with CD45.2 HSCs in competition assays (Waterstrat et al 2010), thus giving the CD45.2 aneuploid donors a slight advantage in these experiments. Additionally, we used CD45.1 recipients to unambiguously quantify the contribution from aneuploid and euploid wild-type littermate donors.…”
Section: Aneuploidy Decreases Hsc Competitive Fitness In Vivomentioning
confidence: 99%
“…Unfortunately, the WT congenic B6.SJL (CD45.1) HSPCs have an inherent disadvantage over WT C57BL/6 (CD45.2) HSPCs, with reported defects in homing efficiency, reduction in transplantable long-term hematopoietic stem cells, and a cell-intrinsic engraftment defect as demonstrated by Waterstrat et al (2010) and us ( Figure 1B). This advantage is particularly marked if C57BL/6J mice are used as recipients and is mildly attenuated when B6.SJL mice are used as recipients, suggesting that B6.SJL cells may be impaired in their ability to interact with C57BL/6J stromal cells (Waterstrat et al, 2010). This lack of competitive balance between the two putatively congenic strains has called into question the interpretation of prior results concerning the impact of modified genes and has created a conundrum for the field.…”
Section: Introductionmentioning
confidence: 98%
“…The CD45 gene is inherited within a locus that comprises almost 40 megabases and more than 300 predicted genes (Waterstrat et al, 2010 (Sacca et al, 2013). Thus, the ideal control for HSPC characterization of these new strains is a functionally equivalent C57BL/6N mouse with the minimal change in the CD45 gene to render it detectable by a CD45.1 antibody.…”
Section: Introductionmentioning
confidence: 99%
“…S2A). While CD45.2 hematopoietic cells have an inherent engraftment advantage [15,16], we found that the CD45.1 WT HSCs outcompeted the CD45.2 b7KO HSCs and thus, the b7KO HSCs had a significantly reduced ability to reconstitute the lymphoid and myeloid lineages as compared to competitor WT HSCs (Fig. 2E and Supplementary Fig.…”
Section: A Subset Of Hscs In the Bm Express B7 Integrinmentioning
confidence: 87%